Browse
Submit Data
Databases
API
Help

Dataset Information

25 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Evaluation of evidence-based patient information on colorectal cancer screening

ABSTRACT: Study hypothesis: Evidence-based patient information leads to more informed choices in colorectal cancer screening than traditional information. Primary outcome(s): Informed choice, consisting of the following three dimensions: 1. Knowledge 2. Uptake of colorectal cancer screening 3. Attitude towards colorectal cancer screening Informed choice is measured using the validated questionnaire "Measure of Informed Choice" 6 weeks after the intervention has been provided. Added as of 05/03/2009: Data analyses of knowledge, attitude and uptake questionnaires will be performed according to a predefined coding guide, which has been deposited at a staff member not involved in the study. Data entry and analyses will be carried out blinded.

PROVIDER: 2418251 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

ChIP-seq from MCF-7 (ENCSR511PAE)

Project description:Reverse Crosslink ControlChIP-seq on human MCF-7 (fragmentation date 03-05-14) For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2017-03-12 | GSE96204 | GEO

Phosphoproteome of patient derived lung cancer cells

Project description:pSTY and pY phosphoproteome analysis of patient derived lung cancer cells, JFCR 28-03, 28-04 and 28-05.

2022-02-08 | PXD028445 | JPOST Repository

MicroRNA profiling of human cholangiocyte H69 cells after culturing with lipopolysaccharide

Project description:H69 cells were cultured in H69 medium with 1 ng/ml lipopolysaccharide(LPS, for smaples 04, 05 and 06) or without LPS(for samples 01, 02 and 03) for 8 hours and then collected for array analysis. <br>

2010-02-11 | E-MEXP-2052 | biostudies-arrayexpress

Randomised Controlled Trial of a Literacy Sensitive Decision Aid for Bowel Cancer Screening

Project description:The purpose of this study is to evaluate a decision aid (written information booklet designed to facilitate informed decision making) to help people aged 55-64 years, with low levels of education and literacy, make an informed choice about bowel cancer screening, using faecal occult blood testing.

| 2062056 | ecrin-mdr-crc

MicroRNA profiling of human cholangiocyte H69 cells after infection with Cryptosporidium parvum

Project description:H69 cells were cultured in H69 medium with Cryptosporidium parvum oocysts(10 X 5 per well, for smaples 04, 05 and 06) or without oocysts(for samples 01, 02 and 03)for 8 hours and then collected for array analysis. Sample 07 was cells exposed to heated inactived oocysts. <br>

2010-02-11 | E-MEXP-2050 | biostudies-arrayexpress

DRUGseq U2OS cells treated with small molecules

Project description:We report the transcriptional changes associated with treatment of U2OS osteosarcoma cell line with DMSO, ND-09-QY33, CA-90-VK59, JC-68-AL90, MB-03-IE36, JC-43-ZO95, PA-33-CK45, KA-73-NB69, QC-05-UB63, SE-15-AV21, NV-67-DX31, DB-85-YA47, NA-37-JQ34, VA-76-OV33, & LD-22-SA99

2021-06-05 | GSE176150 | GEO

Assessing the influence of distinct IVF culture media on human pre-implantation development using single-embryo transcriptomics

Project description:The use of Assisted Reproductive Technologies (ART) is rising consistently across the world. However, making an informed consent on the choice of which embryo culture media should be preferred to ensure satisfactory success rates and the future children to be healthy lacks scientific knowledge. Particularly, embryos within their first days are highly sensitive to their micro-environment with limited stress tolerance mechanisms. Here, we aimed to determine whether culture media that differed markedly in their composition used before compaction would affect gene expression and subsequent human embryonic development.

2023-06-19 | GSE212811 | GEO

Transcriptomic comparison of a second-generation AKT degrader to the catalytic AKT inhibitor GDC0068 in breast cancer cells [PRO-seq]

Project description:We report the development of a second-generation AKT degrader INY-05-040, which outperformed catalytic AKT inhibition both with respect to biochemical and cellular suppression of AKT/mTORC1-driven phenotypes in diverse breast cancer cell lines. Using multi-omic profiling and causal network integration, we demonstrate that the enhanced efficacy of INY-05-040 relies in part on potent downstream activation of stress mitogen activated protein kinase (MAPK) signaling. Systematic measurements of growth inhibition across 288 cancer cell lines confirmed the substantial improvement in potency for INY-05-040 compared to the first-generation AKT degrader (INY-03-041) and catalytic AKT inhibition with GDC-0068. Subsequent integration of breast cancer cell line-specific data with publicly available transcriptomic, proteomic and reverse phase protein array (RPPA) measurements revealed that decreased sensitivity to INY-05-040 correlates with a high baseline activation of inflammatory/stress signaling pathways. Collectively, our data uncover a unique mechanism of breast cancer cell line sensitivity to AKT degradation, further suggesting that the efficacy of catalytic AKT inhibition may be enhanced by activation of stress MAPKs in breast cancer cells with low baseline activity of these components.

2022-10-15 | GSE206388 | GEO

Transcriptomic comparison of a second-generation AKT degrader to the catalytic AKT inhibitor GDC0068 in breast cancer cells [RNA-seq]

2022-10-15 | GSE206385 | GEO

Promoting Veteran-Centered Colorectal Cancer Screening

Project description:Systematic efforts to improve colorectal cancer screening use in the VA Healthcare System have resulted in an increase in not only appropriate, but also inappropriate use of screening. The purpose of this study is to test a new, more patient-centered approach to colon cancer screening. In older individuals (ages 70 to 75) who are "due" for screening, the investigators will provide education on the benefits and harms of colon cancer screening. But instead of simply providing these patients with "average" information about these benefits, the investigators will give them information that takes into account their personal characteristics (e.g., age, gender), overall health, and screening history and therefore applies to them more personally. The investigators will also work with the health system to create time and space for patient and doctor to discuss whether screening is the right choice for each individual. This way, patients can make an informed choice about what is right for them, with the help of their doctor. In the future, the results of this study will help patients make more informed screening decisions, especially when the benefits of screening may be uncertain for them personally.

| 2158114 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data